Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non A, non B-hepatitis in children].

C Bosch, H W Rotthauwe, M Becker

    Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde
    |September 1, 1982
    PubMed
    Summary

    Non-A, Non-B (NANB) hepatitis in children can lead to severe outcomes, including liver failure and chronic disease. NANB hepatitis often has a prolonged course, with chronic NANB hepatitis showing a poorer prognosis than hepatitis B.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa.

    IJTLD open·2024
    Same author

    Volar locking plate fixation of distal radius fractures: Isokinetic assessment of the influence of an ulnar styloid process fracture on pronation-supination strength.

    Hand surgery & rehabilitation·2019
    Same author

    Architecture of a mammalian glomerular domain revealed by novel volume electroporation using nanoengineered microelectrodes.

    Nature communications·2018
    Same author

    Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2017
    Same author

    [Surgical exposures for distal radius fractures].

    Hand surgery & rehabilitation·2016
    Same author

    Temporal trends in classical and alternative flame retardants in bird eggs from Doñana Natural Space and surrounding areas (south-western Spain) between 1999 and 2013.

    Chemosphere·2015

    Area of Science:

    • Pediatric Gastroenterology
    • Hepatology
    • Viral Hepatitis Research

    Context:

    • Non-A, Non-B (NANB) hepatitis represents a significant concern in pediatric liver disease.
    • Parenteral transmission is a likely route of infection in many pediatric cases.
    • NANB hepatitis accounted for approximately 11% of acute viral hepatitis and 17% of chronic hepatitis cases in children during the study period.

    Purpose:

    • To describe the clinical characteristics, outcomes, and prognosis of acute and chronic Non-A, Non-B hepatitis in children.
    • To compare the presentation and course of NANB hepatitis with other viral hepatitis etiologies.
    • To evaluate the long-term sequelae of NANB hepatitis in a pediatric cohort.

    Summary:

    • The study reviewed 10 children with acute and 8 with chronic NANB hepatitis between 1975-1980.
    • Acute NANB hepatitis frequently presented with anicteric disease and mild transaminase elevation, often with poor outcomes including acute liver failure and progression to chronic hepatitis.
    • Chronic NANB hepatitis showed variable courses, with chronic persistent NANB hepatitis being benign, but chronic active NANB hepatitis having a poorer prognosis than chronic active hepatitis B.

    Impact:

    • NANB hepatitis in children can have a prolonged and severe course, with a higher risk of progression to chronic liver disease compared to other hepatitis types.
    • Chronic active NANB hepatitis in children carries a worse prognosis than its counterpart in hepatitis B.
    • Findings highlight the importance of understanding and managing NANB hepatitis in pediatric populations, particularly regarding long-term outcomes and potential for chronic liver disease.

    Related Experiment Videos